Robert E. Funck, Vice President, Controller at ABBOTT LABORATORIES (ABT), sold 4,171 shares at $39.30 ($165K) on 2016-02-29, disclosed to the SEC on 2016-03-02.
Scheduled sale ($165k) by Vice President, Controller under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.30 | 100 | $4K | 2.4% |
| 2 | $39.30 | 300 | $12K | 7.2% |
| 3 | $39.31 | 933 | $37K | 22.3% |
| 4 | $39.52 | 2,838 | $112K | 68.2% |
| Total | $39.45 avg | 4,171 | $165K | 100% |
| Filing → |
| ABT | SELL | 2019-03-04 | $78K | — | Filing → |
| ABT | SELL | 2018-03-02 | $144K | — | Filing → |
| ABT | SELL | 2017-02-24 | $1.2M | — | Filing → |